通过PF-00835231抑制冠状病毒主要蛋白酶的结构基础
Xuelan Zhou1, Xiaolu Lu1, Cheng Lin2
1College of Pharmacy, Gannan Medical University, Ganzhou 341000, China.
Acta biochimica et biophysica Sinica
|July 30, 2024
概括
PF-00835231有效地抑制了SARS-CoV-2主要蛋白酶 (Mpro) 和其变体. 结构分析揭示了针对多种冠状病毒的广泛抗病毒潜力,有助于新药开发.
科学领域:
- 病毒学 病毒学
- 结构生物学 结构生物学
- 药物发现 药物发现 药物发现
背景情况:
- 主蛋白酶 (Mpro) 对于冠状病毒复制至关重要,也是关键的药物标.
- PF-00835231是SARS-CoV-2 Mpro. 的一个强有力的抑制剂.
研究的目的:
- 评估PF-00835231对SARS-CoV-2 Mpro及其突变的抑制活性.
- 确定不同冠状病毒中PF-00835231抑制的结构基础.
主要方法:
- 进行了酶抑制试验.
- 确定了PF-00835231的Mpro复合物的晶体结构,用于SARS-CoV-2,SARS-CoV,MERS-CoV和七种SARS-CoV-2突变.
主要成果:
- PF-00835231证明了对各种Mpro酶的广泛抑制.
- 结构数据揭示了抑制的关键决定因素和阐明的结合模式.
结论:
- PF-00835231对冠状病毒Mpro.表现出广泛的疗效.
- 结构洞察力有助于为人类冠状病毒设计新的广泛抗病毒剂.
相关概念视频
Enzyme Inhibition
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...


